LAUSR

Abstract Aim To evaluate the clinical outcome and the associated factors of a treatment protocol for peri‐implant mucositis. Materials and Methods Patients were evaluated 30 months after a treatment protocol including professional mechanical debridement and modification of the prosthesis contours to improve access for biofilm control. Clinical performance was assessed by means of probing with an electronic pressure‐calibrated periodontal probe. The possible impact of implant‐ and patient‐level factors on the changes in peri‐implant mucosal inflammation measured with the modified bleeding index (mBI) was evaluated. Results Twenty patients and 61 implants were included in the analysis. At the final visit, 50% of the patients presented bleeding on probing, with a mean mBI of 0.22 (SD 0.27). The adjusted linear regression model showed a significant association between patient's compliance with supportive care visits (p = .006) and mucosal inflammation. Similarly, at the implant level, modified plaque index (p < .001) and an irregular use of interdental brushes (p = .017) had a significant impact on final mBI. Conclusions Prosthesis modification when needed in association with non‐surgical treatment may be an important intervention in the treatment of peri‐implant mucositis. Compliance with supportive care visits and the regular use of inter‐dental brushes were identified as important factors to achieve mucosal inflammation control.